Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials

Thread starter International: Top News And Analysis
Start date Thursday at 1:03 PM

International: Top News And Analysis

Guest

Thursday at 1:03 PM

There are now positive results from five late-stage trials on retatrutide, which Lilly is positioning as the next pillar of its obesity portfolio.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials

Prefix: N/A

Forum: World News

Start date: Thursday at 1:03 PM

Last reply date: Thursday at 1:03 PM

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Thursday at 1:03 PM

Replies: 0

Views: 0

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search